Thai Nakarin Hospital Public Co. Ltd.
28.25
THB
-0.25
(-0.88%)
ISIN
TH0883010R17
Return %
Stock
S&P 500
1Y
-13.74
14.20
3Y
-22.60
81.12
5Y
-13.08
68.34
Capital Structure
THB
•
in mil. unless spec.Working Capital
THB
•
in mil. unless spec.Growth Rates
THB
•
in mil. unless spec.Quarterly Revenue
THB
•
in mil. unless spec.Quarterly Earnings Per Share
THB
•
in mil. unless spec.Quarterly Dividends Per Share
THB
•
in mil. unless spec.Company Description
- CEO
- Thiti Sihanatkathakul
- Full Time Employees
- 1,408
- Sector
- Health services
- Industry
- Hospital/Nursing management
- Address
- No. 345 Thepparat Road km 3.5 Bangkok BM Thailand 10260
- IPO Date
- Dec 16, 2005
- Website
- thainakarin.co.th
- Similar Companies
- Business
- Thai Nakarin Hospital Public Company Limited (TNH.BK) operates a general hospital in Bang Na, Bangkok, providing inpatient, outpatient, and 24-hour emergency medical services through specialized centers and departments; core offerings include the Heart Center, Bone & Joint Center, Holistic Oncology Center with Linear Accelerator radiotherapy, Breast Care Center, Hemodialysis Center, Check-up Center, Skin & Laser Center, Dental Center, Gastrointestinal Center, Lasik Center, Rehabilitation Center, Kidney Transplant Center, Wellness Center, Diabetes & Endocrinology Department, Traditional Chinese Medical Department, Mental Health Department, Hepato-Biliary & Pancreas Department, Medicine Department, Surgery Department, Pediatrics Department, Obstetrics and Gynecology Department, Ear Nose and Throat Department, Eye Department, Emergency Department, ARI Clinic, Laboratory, X-ray, and Physical Therapy departments, alongside operating rooms, ICU, CCU, stroke unit, nursery, and brain/neurology services. The hospital, founded in 1993 and headquartered at 345 Thepparat Road, Bangna, Bangkok, serves primarily Thai patients in eastern Bangkok and eastern Thailand regions, with growing international clientele from CLMV countries and expats comprising 20% of patients, supported by multilingual staff, renovated facilities, and accreditations including Hospital Accreditation (HA) fifth time in 2022 and AACI breast cancer certification in 2023. Recent developments encompass the 2023 launch of Saha Clinic Chachoengsao as the first branch for general care, health checks, vaccinations, and telemedicine referrals; 2024 expansions including an enlarged Lasik Center on the 12th floor, Dental Center improvements, and new equipment such as AI-assisted colonoscopy for colon cancer screening, robotic knee replacement surgery, REZUM steam therapy for enlarged prostate, Enlighten SR picosecond laser for pigmentation and tattoos, and high-frequency echocardiography; planned Q4 2024 openings of Healthy Weight Center for preventive care and Scope Center for gastrointestinal services; integration into the Eastern Cancer Network with Samrong Medical Hospital, Cancer Alliance Sriracha Hospital, and Saha Clinic; and awards like the 2024 Allianz Ayudhya Best Collaboration Award (first place, Group A). The company maintains 190 inpatient beds, over 440 doctors, 550 nurses, and focuses on personalized healthcare, precision medicine, minimally invasive procedures like full endoscopic spine surgery and laparoscopy, mobile checkups, and wellness promotion for corporate, insurance, and self-pay customers amid Thailand's private hospital sector.